Skip to content

Examination of Aromatic Bath's Efficacy in Patients with Anxiety Disorder: Confirmatory, Randomized, Placebo-Controlled, Double-Masked, Multicenter, Collaborative and Comparative Trial

Examination of Aromatic Bath's Efficacy in Patients with Anxiety Disorder: Confirmatory, Randomized, Placebo-Controlled, Double-Masked, Multicenter, Collaborative and Comparative Trial - Examination of Aromatic Bath's Efficacy in Patients with Anxiety Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034422
Enrollment
30
Registered
2018-10-20
Start date
2019-01-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorder

Interventions

Carry lavender scent for 4 weeks Carry distilled water for 4 weeks

Sponsors

Division of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Individuals affected by generalized anxiety disorder or panic disorder Individuals who have used anxiolytic medications more than 7 times in the past month Individuals who do not take aromatherapy baths

Exclusion criteria

Exclusion criteria: Individuals deemed unfit to be a subject in this study by the attending physician due to physical or mental strain that would result from participation in this study Individuals who are pregnant, possibly pregnant, gave birth within the last 28 days or who are breastfeeding Individuals with an olfactory disorder and chronic nasal obstruction Individuals with suicidal thoughts Individuals who take anxiolytic drugs other than benzodiazepines as a medication to be taken as needed at the time of anxiety attack Additionally, individuals deemed ineligible to be a subject in this study by the principal investigators or co-investigators

Design outcomes

Primary

MeasureTime frame
The dosing frequency of anxiolytic drugs

Countries

Japan

Contacts

Public ContactAkihiro Asakawa

Kagoshima University Graduate School of Medical and Dental Sciences Division of Psychosomatic Internal Medicine

asakawa@m2.kufm.kagoshima-u.ac.jp0992755751

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026